封面
市場調查報告書
商品編碼
1392016

放射性示踪劑市場:依類型、應用、最終用戶、地區

Radioactive Tracer Market, By Type, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球放射性示蹤劑市場規模預計將從 2023 年的 32.4 億美元增至 2030 年的 52.6 億美元,預測期內複合年成長率為 7.2%。

報告範圍 報告詳情
基準年 2022年 2023年市場規模 32.4億美元
實績資料 2018-2021 預測期 2023-2030
預測期複合年成長率 7.20% 2030年市場規模預測 52.6億美元
圖 1. 2023 年放射性示蹤劑的全球市場佔有率(依地區分類)
放射性示蹤劑市場-IMG1

放射性示蹤劑已成為許多行業的重要工具,包括醫學、研究和石油探勘。這些示踪劑由發射輻射的放射性物質組成,可以輕鬆檢測和測量。這些用於追蹤特定分子的運動,研究各種生物過程,並確定地下蘊藏量的潛在來源。近年來,隨著放射性示蹤劑在醫療診療、環境領域、石化領域的應用不斷擴大,全球放射性追蹤劑市場出現了顯著成長。

市場動態:

全球放射性示蹤劑市場的成長是由技術進步、慢性病盛行率增加以及個人化醫療需求不斷成長等多種因素所推動的。市場擴大採用正子斷層掃描(PET) 和單光子發射斷層掃描(SPECT) 等診斷影像技術,這些技術利用放射性追蹤劑來檢測和分析各種疾病和狀況,因此取得了顯著的成長。

市場面臨諸如有關放射性材料的使用和處置的嚴格規定等課題。監管機構制定了嚴格的指導方針,以確保放射性示踪劑的安全處理和處置,這顯著增加了製造成本並影響了市場成長。熟練專業人員的有限和與核醫學程序相關的高成本預計將限制市場成長。

儘管有這些課題,全球放射性示蹤劑市場仍充滿成長機會。放射性藥物製造技術新興市場的發展和新放射性同位素市場的開拓預計將為市場相關人員提供新的機會。此外,石油和天然氣探勘、環境監測和工業檢查等行業擴大採用放射性示踪劑,預計也將進一步推動市場成長。

例如,2023年3月16日,製藥公司Telix Pharmaceuticals Limited.宣布,美國食品藥物管理局(FDA)已核准Illuccix(鎵鎵)68戈澤托肽注射的補充新藥認證申請(sNDA)準備套件) 。

本研究的主要特點

  • 該報告對全球放射性示踪劑市場進行了詳細分析,並提出了以2022年為基準年的預測期(2023-2030)的市場規模和年複合成長率(CAGR%)。
  • 該報告還闡明了不同區隔市場的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 該報告還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 該報告根據公司亮點、產品系列、主要亮點、財務實績和策略等參數,介紹了全球放射性示踪劑市場的主要企業。
  • 該報告的見解使行銷人員和經營團隊負責人就未來的產品發布、類型升級、市場擴張和行銷策略做出資訊的決策。
  • 全球放射性示踪劑市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過用於分析全球放射性示蹤劑市場的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與假設

  • 研究目標
  • 假設
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章市場動態、法規及趨勢分析

  • 市場動態
    • 慢性病盛行率增加
    • 放射性藥物的半衰期短
    • 腫瘤學的新應用
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章全球放射性追蹤劑市場-冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章全球放射性示蹤劑市場,依類型,2023-2030

  • 介紹
  • 診斷放射性示踪劑
  • 治療性放射性示蹤劑
  • 其他

第6章 全球放射性示蹤劑市場,依應用分類,2023-2030 年

  • 介紹
  • 腫瘤學
  • 心臟病學
  • 神經病學
  • 甲狀腺
  • 整形外科
  • 內分泌學
  • 其他

第 7 章 全球放射性示蹤劑市場,依最終使用者分類,2023-2030 年

  • 介紹
  • 醫院
  • 專科診所
  • 診斷中心
  • 學術研究所
  • 其他
  • 2018-2030年市場規模及預測、與前一年同期比較成長率

第8章全球放射性示蹤劑市場,依地區,2023-2030

  • 介紹
  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 歐洲其他地區
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 東南亞國協
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第9章競爭形勢

  • PerkinElmer Inc.
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion (Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.

第10章

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6389

Global radioactive tracer market size is expected to reach US$ 5.26 Bn by 2030, from US$ 3.24 Bn in 2023, exhibiting a CAGR of 7.2% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 3.24 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 7.20% 2030 Value Projection: US$ 5.26 Bn
Figure 1. Global Radioactive Tracer Market Share (%), By Region, 2023
Radioactive Tracer Market - IMG1

Radioactive tracers have become an essential tool in several industries including healthcare, research, and oil exploration. These tracers consist of radioactive substances that emit radiation, which can be easily detected and measured. These are used to track the movement of specific molecules, study various biological processes, and identify potential sources of underground reserves. The global radioactive tracer market has witnessed significant growth in recent years, owing to increasing applications of radioactive tracers in medical diagnostics and treatment, and in the environmental and petrochemical sectors.

Market Dynamics:

Global radioactive tracer market growth is driven by several factors including technological advancements, increasing prevalence of chronic diseases, and growing demand for personalized medicine. The market is witnessing significant growth due to rising adoption of diagnostic imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT) that utilize radioactive tracers to detect and analyze various diseases and conditions.

The market faces certain challenges such as stringent regulations related to the use and disposal of radioactive substances. Regulatory bodies impose strict guidelines to ensure the safe handling and disposal of radioactive tracers, wand this significantly increases the cost of production and affects the market growth. The limited availability of skilled professionals and the high cost associated with nuclear medicine procedures are expected to restrain the market growth.

Despite these challenges, global radioactive tracer market is filled with opportunities for growth. Advancements in radiopharmaceutical manufacturing techniques and the development of new radioactive isotopes are expected to create new opportunities for market players. Moreover, increasing adoption of radioactive tracers in industries such as oil and gas exploration, environmental monitoring, and industrial testing is expected to drive the market growth further.

For instance, on March 16, 2023, Telix Pharmaceuticals Limited., a pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) had approved a supplementary New Drug Application (sNDA) for Illuccix (kit for the preparation of gallium Ga 68 gozetotide injection) to enable patients with metastatic prostate cancer, for whom 177Lu 177 PSMA-directed therapy is indicated.

Key features of the study:

  • This report provides in-depth analysis of the global radioactive tracer market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global radioactive tracer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include PerkinElmer Inc., Cardinal Health, Bracco, NTP Radioisotopes, Nordion (Canada) Inc., Curium, IRE, Telix Pharmaceuticals Limited, NorthStar Medical Radioisotopes, LLC, Lantheus Holdings, Inc., Eckert & Ziegler, Siemens Healthineers, GE Healthcare, Mallinckrodt Nuclear Medicine LLC, Jubilant DraxImage Inc., and Sumitomo Heavy Industries, Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global radioactive tracer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global radioactive tracer market

Detailed Segmentation:

  • By Type
    • Diagnostic Radioactive Tracers
    • Therapeutic Radioactive Tracers
    • Others
  • By Application
    • Oncology
    • Cardiology
    • Neurology
    • Thyroid
    • Orthopedic
    • Endocrinology
    • Others
  • By End User
    • Hospitals
    • Specialty Clinics
    • Diagnostic Centers
    • Academic & Research Institutes
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top companies in Global Radioactive Tracer Market:
    • PerkinElmer Inc.
    • Cardinal Health
    • Bracco
    • NTP Radioisotopes
    • Nordion (Canada) Inc.
    • Curium
    • IRE
    • Telix Pharmaceuticals Limited
    • NorthStar Medical Radioisotopes, LLC
    • Lantheus Holdings, Inc.
    • Eckert & Ziegler
    • Siemens Healthineers
    • GE Healthcare
    • Mallinckrodt Nuclear Medicine LLC
    • Jubilant DraxImage Inc.
    • Sumitomo Heavy Industries, Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Radioactive Tracer, By Type
    • Market Radioactive Tracer, By Application
    • Market Radioactive Tracer, By End User
    • Market Radioactive Tracer, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing prevalence of chronic diseases
    • Short half-life of radiopharmaceuticals
    • Emerging applications in oncology
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Radioactive Tracer Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Radioactive Tracer Market, By Type, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Diagnostic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Therapeutic Radioactive Tracers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Radioactive Tracer Market, By Application, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cardiology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Neurology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Thyroid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Orthopedic
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Endocrinology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Radioactive Tracer Market, By End User, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Academic & Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Radioactive Tracer Market, By Region, 2023-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Country 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,( US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • PerkinElmer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Cardinal Health
  • Bracco
  • NTP Radioisotopes
  • Nordion (Canada) Inc.
  • Curium
  • IRE
  • Telix Pharmaceuticals Limited
  • NorthStar Medical Radioisotopes, LLC
  • Lantheus Holdings, Inc.
  • Eckert & Ziegler
  • Siemens Healthineers
  • GE Healthcare
  • Mallinckrodt Nuclear Medicine LLC
  • Jubilant DraxImage Inc.
  • Sumitomo Heavy Industries, Ltd.
  • Analyst Views

10. Section

  • Research Methodology
  • About us